24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Saint Louis University
Medical School
Baptist Memorial Hospital
Residency
Memorial Sloan-Kettering Cancer Center
Fellowship
American Board of Internal Medicine - Oncology
Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.
Stewart, C. F.,Tagen, M.,Schwartzberg, L. S.,Blakely, L. J.,Tauer, K. W.,Smiley, L. M.; Cancer Chemother. Pharmacol.. 2014 Jan 23.
See more >>
33 citations Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2-Negative Advanced Breast Cancer That Progressed during or after Bevacizumab.
Schwartzberg, L. S.,Tauer, K. W.,Hermann, R. C.,Makari-Judson, G.,Isaacs, C.,Beck, J. T.,Kaklamani, V.,Stepanski, E. J.,Rugo, H. S.,Wang, W.,Bell-McGuinn, K.,Kirshner,...; Clin. Cancer Res.. 2013 May 15.
See more >>
Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV).
Hudis C, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani VG, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn KM, Chera H, Zaugg B, Ro SK, Li S, Schwart...; J. Clin. Oncol.. 2011-05-20.
See more >>
